Ngenla

somatrogon-ghla

Approval

ApplicationBLA 761184
Approval dateJun 27, 2023
Approval year2023
SponsorPfizer Ireland Pharmaceuticals

FDA-approved use

To treat growth failure due to inadequate secretion of endogenous growth hormone

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Ngenla: